[1]
2026. STUDY OF FIBROSIS PATHWAYS (TGF-Β AND WNT SIGNALING) AS THERAPEUTIC TARGETS IN CHRONIC KIDNEY DISEASE. MSW Management Journal. 36, 1s (Apr. 2026), 2466–2470. DOI:https://doi.org/10.7492/6nvwdg38.